Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin for Fatigue in Advanced Cancer
NCT00925899Phase 3Completed
- Sponsor
- Bispebjerg and Frederiksberg Hospital
- Start
- Oct 2009
- Primary completion
- Mar 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in cancer comparing Melatonin with Placebo (2 arms). Primary endpoint: Physical Fatigue Scale (MFI-20) at 1 week. Started Oct 2009; status: completed.
02
Drugs
melatonin
03
Conditions
cancer
Beyond the preview
Go deeper on NCT00925899.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00925899.